Lithium Monitoring — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Every 6 months
The correct answer is E: every 6 months. NICE CG185 recommends measuring plasma lithium levels every 3 months during the first year and every 6 months thereafter in patients without additional risk factors. Three-monthly monitoring is required after the first year for older people and for those taking interacting medicines, at risk of renal, thyroid or calcium-related complications, with poor symptom control or adherence, or whose most recent lithium level was 0.8 mmol/L or higher. None applies here. Monthly monitoring is not routine for stable long-term treatment, while annual or symptom-triggered testing is too infrequent because lithium has a narrow therapeutic index and toxicity may develop without a preceding change in psychiatric symptoms.
Reference: National Institute for Health and Care Excellence. Bipolar disorder: assessment and management (CG185), section 1.10, recommendation 1.10.20. 2014, updated 2025. https://www.nice.org.uk/guidance/cg185/chapter/Recommendations